Research Team

As principal investigator in the Nanomedicine and Extracellular Vesicles Lab, Dr. Wolfram leads a team that is advancing nanomedicine research. Her team's discoveries could ultimately lead to increased therapeutic efficacy and reduced side effects of treatment for breast cancer, cardiovascular diseases and other conditions.

Learn more about Dr. Wolfram and members of her research team.

Joy Emelie (Joy) V. Wolfram, Ph.D.

Dr. Wolfram is a faculty member in the Department of Transplantation at Mayo Clinic in Jacksonville, Florida.

Dr. Wolfram also holds positions with several other institutions, including faculty and professorship appointments. Learn more about Dr. Wolfram's professional highlights.

Dr. Wolfram is the author of numerous scientific publications and has received several scientific awards from around the world.

In 2016, she was named in the Amgen Scholars Ten to Watch List, which highlights the best and brightest up-and-comers in science and medicine. In 2017, Dr. Wolfram was selected together with Nobel laureates, prominent authors and professional athletes to represent one of 12 internationally accomplished Finns in the 2017 Inspired in Finland campaign celebrating Finland's 100 years of independence.

Sara Busatto, Ph.D.

Dr. Busatto is a postdoctoral fellow in the lab. Dr. Busatto's research focuses on exploring the role of extracellular vesicles as mediators of metastasis. In particular, she is studying how extracellular vesicles derived from cancer cells interact with endothelial barriers.

Dr. Busatto was awarded a doctorate in health technology in 2018 and a master's degree in medical biotechnology in 2015, both from the University of Brescia in Italy. She has several publications in the field of extracellular vesicles and has been an invited speaker at national conferences.

Anthony N. Pham, M.S.

Anthony Pham is a special project associate in the Nanomedicine and Extracellular Vesicles Lab. His research focuses on the use of extracellular vesicles in the treatment of neointimal hyperplasia, a condition that leads to restenosis after angioplasty to treat cardiovascular disease.

Pham graduated from Vanderbilt University in Nashville, Tennessee, in 2017 with a bachelor's degree in medicine, health and society. He received a master's degree in physiology from Georgetown University in Washington, D.C., in 2018.

Ming Tian, M.D.

Dr. Tian is a visiting Ph.D. student from Heidelberg University in Germany. His research in Dr. Wolfram's laboratory involves assessing the regenerative capacity of adipose-derived components in organ regeneration. Dr. Tian received a bachelor's degree from Wuhan University in China in 2013. He graduated from Lanzhou University with a medical degree in surgery in 2016. He has previous research experience in patient-derived organoids and personalized medicine, and has authored several publications.

Yuexiao (Fiona) Li, M.D.

Dr. Li is a visiting research fellow in Dr. Wolfram's laboratory. As a first-year Ph.D. student in oral and maxillofacial surgery at China Medical University, her research interest is in the study of extracellular vesicles in various oral and maxillofacial conditions. Dr. Li received a bachelor's degree in 2012 and a medical degree in 2015 from China Medical University. She is an oral surgeon with clinical expertise in oral cancers and a special emphasis on reconstructive surgery and salivary gland neoplasms.

Sierra A. Walker, B.A.

Sierra A. Walker is a Ph.D. student in the biochemistry and molecular biology track at Mayo Clinic Graduate School of Biomedical Sciences. Her work in the lab aims to identify the role of surface glycans on extracellular vesicles derived from cancer cells in metastasis. Walker received her bachelor's degree from North Dakota State University in Fargo, North Dakota, in 2017.

Marlon Brandon Griggs

Brandon Griggs is a student researcher from Florida State College at Jacksonville who's investigating the application of extracellular vesicles as a medium for the delivery of various therapeutics.

When he's not in the lab, Griggs is interested in the democratization of the science field for all, particularly minority students. He raises awareness for this issue in his capacity as a spokesperson for the Coalition for Youth Justice and founder of Hear the Youth, an organization that provides kids with opportunities for personal growth and development. Griggs is also a part of his school's EVAC movement and is a TEDx speaker on the topic of improving youth outcomes in the juvenile justice system.

Xinghua Wang, Ph.D.

Dr. Wang is a visiting scientist from Tianjin Institute of Cardiology in China. Her research in our lab focuses on developing new adipose-derived therapies for lung ischemia-reperfusion injury. Dr. Wang received a Ph.D. from Tianjin Medical University in China in 2018. She has experience in noncoding RNA (microRNAs and long noncoding RNAs) signaling pathways in cardiovascular diseases and cancer.

Man Yang , Ph.D.

Dr. Yang is a visiting associate professor from the Capital Medical University in Beijing. Her research in our lab focuses on understanding interactions between macrophages and extracellular vesicles during inflammation.

Dr. Yang received a Ph.D. from Peking Union Medical College in China in 2011. She has experience in the application and safety evaluation of nanomaterials, including immunological effects of nanoparticles, tumor treatment approaches of nanomaterials, and the mechanisms of inflammatory reactions caused by nanomaterials. She has published more than 30 articles in the field of nanotechnology.

Yubo Yang, Ph.D.

Dr. Yang is a postdoctoral fellow from West China Hospital associated with Sichuan University in China. He received a bachelor's degree from Shanghai Jiao Tong University in 2015 and a master's degree from Sichuan University in 2018. As a Ph.D. student and a surgeon specializing in urinary malignances, Dr. Yang is interested in the use of liquid biopsies and overcoming cancer drug resistance. His previous research focused on circulating tumor cells in bladder cancer. He has several first author publications in the field of cancer research.